# Xiidra

NDC: 24208-911
Generic name: Lifitegrast
Labeler / Manufacturer: Bausch & Lomb Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20240102

FDA application: NDA208073

## Active ingredients

- LIFITEGRAST: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24208-911"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24208-911
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a914080-a3c0-44be-b601-0ae3160e77eb